abstract |
Provided are compounds that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as products containing such compounds, and methods for their use and synthesis. Such compounds are of formula (I): [Wherein A, J, W 1 , Y, Z, R 1 , R 2 , R 3 and R 4 are as defined herein. ] Or a pharmaceutically acceptable salt thereof. |